Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/31244
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVitali, F-
dc.contributor.authorWiegand, JP-
dc.contributor.authorParker-Halstead, L-
dc.contributor.authorTucker, A-
dc.contributor.authorDiaz Brinton, R-
dc.date.accessioned2025-05-15T10:01:25Z-
dc.date.available2025-05-15T10:01:25Z-
dc.date.issued2025-01-24-
dc.identifierORCiD: Francesca Vitali https://orcid.org/0000-0003-2916-6402-
dc.identifierORCiD: Allan Tucker https://orcid.org/0000-0001-5105-3506-
dc.identifierArticle number: e0314097-
dc.identifier.citationVitali, F. et al. (2025) 'Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer’s risk population: A retrospective analysis', PLOS ONE, 20, e0314097, pp. 1 - 20. doi: 10.1371/journal.pone.0314097.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/31244-
dc.descriptionData Availability: All relevant data are within the manuscript and its Supporting Information files. Python code along with data are available at https://github.com/fransiss/AHMM_mouse_trajectories.en_US
dc.descriptionSupporting information is available online at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0314097#sec016 .-
dc.description.abstractTranslational validity of mouse models of Alzheimer’s disease (AD) is variable. Because change in weight is a well-documented precursor of AD, we investigated whether diversity of human AD risk weight phenotypes was evident in a longitudinally characterized cohort of 1,196 female and male humanized APOE (hAPOE) mice, monitored up to 28 months of age which is equivalent to 81 human years. Autoregressive Hidden Markov Model (AHMM) incorporating age, sex, and APOE genotype was employed to identify emergent weight trajectories and phenotypes. In the hAPOE-AD mouse cohort, five distinct weight trajectories emerged: three trajectories were associated with a weight loss phenotype (36% of mice, n = 426), one with weight gain (13% of mice, n = 152), and one trajectory of no change in weight (34% of mice, n = 403). The AHMM model findings were validated with post-hoc survival analyses, revealing differences in survival rates across the five identified phenotypes. Further validation was performed using body composition and plasma β-amyloid data from mice within the identified gain, loss and stable weight trajectories. Weight gain trajectory was associated with elevated plasma β-amyloid levels, higher body fat composition, lower survival rates and a greater proportion of APOE4/4 carriers. In contrast, weight loss was associated with greater proportion of hAPOE3/ 4 carriers, better survival rates and was predominantly male. The association between weight change and AD risk observed in humans was mirrored in the hAPOE-AD mouse model. Weight trajectories of APOE3/3 mice were equally distributed across weight gain, loss and stability. Surprisingly, despite genetic uniformity, comparable housing, diet and handling, distinct weight trajectories and divergence points emerged for subpopulations. These data are consistent with the heterogeneity observed in the human population for change in body weight during aging and highlight the importance of longitudinal phenotypic characterization of mouse aging to advance the translational validity of preclinical AD mouse models.en_US
dc.description.sponsorshipResearch reported herein was supported by the National Institute on Aging (grants P01AG026572 [Perimenopause in Brain Aging and Alzheimer's Disease], T32AG061897 [Translational Research in Alzheimer's Disease and Related Dementias (TRADD)], 5R01AG057931-02 [Sex Differences in Molecular Dementias of Alzheimer's Disease Risk: Prodromal Endophenotype]), the Women's Alzheimer's Movement to Roberta Diaz Brinton, and the University of Arizona Center for Innovation in Brain Science.en_US
dc.format.extent1 - 20-
dc.format.mediumElectronic-
dc.language.isoen_USen_US
dc.publisherPLOSen_US
dc.rightsAttribution 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectbody weighten_US
dc.subjectmouse modelsen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectweight lossen_US
dc.subjectblood plasmaen_US
dc.subjectweight gainen_US
dc.subjecthidden Markov modelsen_US
dc.subjectmedical risk factorsen_US
dc.titleWeight trajectories in aging humanized APOE mice with translational validity to human Alzheimer’s risk population: A retrospective analysisen_US
dc.typeArticleen_US
dc.date.dateAccepted2024-11-06-
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0314097-
dc.relation.isPartOfPLOS ONE-
pubs.publication-statusPublished-
pubs.volume20-
dc.identifier.eissn1932-6203-
dc.rights.licensehttps://creativecommons.org/licenses/by/4.0/legalcode.en-
dcterms.dateAccepted2024-11-06-
dc.rights.holderVitali et al.-
Appears in Collections:Dept of Computer Science Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright: © 2025 Vitali et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.2.07 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons